RESOURCES

Accelerating the Development of Next-generation Therapeutics for Obesity | Product solutions guide (product list) for obesity therapeutics development. Combining comprehensive target coverage for key targets (GLP-1R, GIPR, GCGR, Amylin/Calcitonin, & more) with clinically proven technology platform and cell-based assay products to accelerate your path from concept to clinic by cutting months or even years from your development timeline.

Accelerate innovation with complete kinase solutions

Early safety insights can make or break a program. Discover how current industry thinking and practical strategies to help you apply secondary pharmacology more effectively, so you can make risk-informed decisions earlier.

Ion channels are essential targets in drug discovery due to their critical roles in cellular signaling, electrical activity, and homeostasis.

Accelerate Your Drug Discovery with Industry-leading Metabolic Disorder Obesity Solutions

Accelerate Your Drug Discovery with Our State-of-the-Art Chemistry Services

A subset of G Protein-Coupled Receptors detect changes in extracellular H+ concentrations at pH values near the physiological range(pH 6.5 to 7.5).

Accelerate your candidate selection with industry-leading ADME Services

The Eurofins Discovery Protein Degradation and PROTAC Discovery Portfolio includes a comprehensive suite of target-based, cellular, and phenotypic approaches for a powerful drug discovery resource in the targeted protein degradation space.

Reliable chemistry, target-based and cellular functional services, and products to help you design successful and fully tailored screening cascades

Improve Discovery Cycle Times with Chemistry & ADME Services Under One Roof

Discover Metabolism and Safety Risks Early in Development